Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
P Gounopoulos, E Merki, LF Hansen… - Minerva …, 2007 - europepmc.org
The pathogenesis of atherosclerosis is mediated by genetic susceptibility along with a
variety of cardiovascular risk factors and environment influences. As atherosclerotic lesions …
variety of cardiovascular risk factors and environment influences. As atherosclerotic lesions …
Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease
T Lehtimäki, S Lehtinen, T Solakivi… - … , and vascular biology, 1999 - Am Heart Assoc
Oxidation of low density lipoproteins (LDL) obviously plays an important role in the
pathogenesis of atherosclerosis. The purpose of the study was to determine whether …
pathogenesis of atherosclerosis. The purpose of the study was to determine whether …
Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques
I Gonçalves, MLM Gronholdt, I Söderberg… - … , and vascular biology, 2005 - Am Heart Assoc
Background—Immune responses against oxidized low-density lipoprotein (LDL) play an
important role in atherosclerosis. The aim of this study was to investigate if humoral immune …
important role in atherosclerosis. The aim of this study was to investigate if humoral immune …
Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis
W Palinski, JL Witztum - Journal of internal medicine, 2000 - Wiley Online Library
Palinski W, Witztum JL (University of California San Diego, La Jolla, California, USA).
Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the …
Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the …
Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes
GN Fredrikson, DV Anand, D Hopkins, R Corder, R Alm… - Diabetologia, 2009 - Springer
Aims/hypothesis Oxidation of LDL in the arterial extracellular matrix is a key event in the
development of atherosclerosis and autoantibodies against oxidised LDL antigens reflect …
development of atherosclerosis and autoantibodies against oxidised LDL antigens reflect …
Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study
Objectives: We investigated whether associations exist between immune reactions to
oxidized low-density lipoproteins (OxLDLs), chronic infections, and carotid atherosclerosis …
oxidized low-density lipoproteins (OxLDLs), chronic infections, and carotid atherosclerosis …
Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease
J Nilsson, G Nordin Fredrikson… - Current …, 2007 - ingentaconnect.com
Immune responses against oxidized forms of LDL play a critical role in activation and
regulation of the inflammatory process that characterizes all stages of atherosclerosis. In …
regulation of the inflammatory process that characterizes all stages of atherosclerosis. In …
Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis
A Schiopu, J Bengtsson, I Söderberg… - Circulation, 2004 - Am Heart Assoc
Background—Accumulation and oxidation of LDL are believed to be important initiating
factors in atherosclerosis. Oxidized LDL is recognized by the immune system, and animal …
factors in atherosclerosis. Oxidized LDL is recognized by the immune system, and animal …
Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin …
AE Fraley, GG Schwartz, AG Olsson, S Kinlay… - Journal of the American …, 2009 - jacc.org
Objectives: This study sought to define the relationship between oxidative biomarkers,
cardiovascular disease (CVD) risk factors, and inflammatory and thrombosis biomarkers …
cardiovascular disease (CVD) risk factors, and inflammatory and thrombosis biomarkers …
A role for autoantibodies in atherogenesis
An increased risk of cardiovascular disease (CVD) has long been recognized amongst
people with autoimmune disease. It has been unclear whether this is due mainly to the …
people with autoimmune disease. It has been unclear whether this is due mainly to the …